Lido Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.3M Buy
33,950
+133
+0.4% +$16.8K 0.02% 386
2025
Q1
$4.33M Buy
33,817
+1,580
+5% +$202K 0.02% 356
2024
Q4
$4.26M Sell
32,237
-3,786
-11% -$501K 0.02% 337
2024
Q3
$5.25M Sell
36,023
-4,336
-11% -$631K 0.03% 281
2024
Q2
$5.54M Buy
40,359
+907
+2% +$124K 0.03% 256
2024
Q1
$5.41M Buy
39,452
+968
+3% +$133K 0.03% 256
2023
Q4
$5.23M Buy
38,484
+1,340
+4% +$182K 0.04% 243
2023
Q3
$4.54M Buy
37,144
+1,769
+5% +$216K 0.03% 245
2023
Q2
$4.49M Buy
35,375
+2,662
+8% +$338K 0.03% 227
2023
Q1
$4.23M Buy
32,713
+312
+1% +$40.3K 0.04% 216
2022
Q4
$4.25M Buy
32,401
+1,073
+3% +$141K 0.05% 176
2022
Q3
$3.66M Buy
31,328
+1,330
+4% +$156K 0.05% 166
2022
Q2
$3.53M Sell
29,998
-379
-1% -$44.6K 0.05% 147
2022
Q1
$3.96M Sell
30,377
-1,185
-4% -$154K 0.04% 154
2021
Q4
$4.82M Buy
31,562
+3,935
+14% +$600K 0.05% 152
2021
Q3
$4.47M Buy
27,627
+4,574
+20% +$739K 0.06% 151
2021
Q2
$3.77M Buy
23,053
+3,142
+16% +$514K 0.05% 158
2021
Q1
$3M Buy
19,911
+1,345
+7% +$203K 0.05% 162
2020
Q4
$2.81M Sell
18,566
-841
-4% -$127K 0.06% 158
2020
Q3
$2.63M Buy
19,407
+814
+4% +$110K 0.07% 130
2020
Q2
$2.54M Buy
18,593
+1,673
+10% +$229K 0.08% 122
2020
Q1
$1.82M Sell
16,920
-1,408
-8% -$152K 0.08% 127
2019
Q4
$2.21M Buy
18,328
+2,827
+18% +$341K 0.09% 115
2019
Q3
$1.54M Buy
15,501
+494
+3% +$49.1K 0.08% 133
2019
Q2
$1.64M Buy
15,007
+142
+1% +$15.5K 0.09% 117
2019
Q1
$1.66M Buy
14,865
+9,435
+174% +$1.05M 0.11% 111
2018
Q4
$523K Buy
5,430
+1,174
+28% +$113K 0.05% 202
2018
Q3
$519K Buy
4,256
+875
+26% +$107K 0.05% 218
2018
Q2
$371K Buy
3,381
+585
+21% +$64.2K 0.04% 250
2018
Q1
$298K Buy
2,796
+437
+19% +$46.6K 0.04% 269
2017
Q4
$251K Buy
2,359
+157
+7% +$16.7K 0.04% 242
2017
Q3
$230K Buy
+2,202
New +$230K 0.04% 235